Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Introducción del caso

This program is divided into several short segments that you can access using the Video Chapters menu.
person default
Ariel Campos, MD
Luis E. Soto-Ramirez, MD
Released: July 29, 2022
PreviousNext

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

Expert insights on HIV PrEP medications, guideline updates, and solutions to uptake barriers, from Dr Gregory Huhn and Clinical Care Options (CCO)

Gregory Huhn, MD, MPHTM Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 12, 2022 Expired: August 11, 2023

Clinical Care Options (CCO) commentary from Dr Darrell Tan on the dosing options for long-acting injectable cabotegravir plus rilpivirine for HIV treatment

Babafemi Taiwo, MBBS
Program Director
Darrell H. S. Tan, MD, FRCPC, PhD
Released: August 12, 2022

Gregory Huhn, MD, MPHTM Released: August 12, 2022

Clinical Care Options (CCO) expert Carolyn Chu, MD, MSc, discusses how to improve HIV pre-exposure prophylaxis accessibility and availability for PWID

person default Carolyn Chu, MD, MSc, FAAFP, AAHIVS Released: August 12, 2022

Video Chapters


Beca educativa proporcionada por:
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings